van den Bosch Maurice A A J, Daniel Bruce L
Department of Radiology, University Medical Center Utrecht, Heidelberglaan 100, 3584CX Utrecht, The Netherlands.
Magn Reson Imaging Clin N Am. 2005 Aug;13(3):505-17. doi: 10.1016/j.mric.2005.04.003.
Techniques and instrumentation are now widely available that enable interventional MR-guided preoperative needle localization and lesion marking. Minimally invasive MR-guided core biopsy techniques have been demonstrated but remain limited for small lesions and will be facilitated by the development of biopsy instruments that can be directly visualized using MR imaging. MR-guided tumor ablation is beginning to be evaluated in a few centers. It holds promise as new treatment modality in the continuing trend toward greater breast conservation in the local therapy of breast cancer. Further studies are needed to document the ability of MR-guided ablation to control the margins of a tumor as effectively as surgery. Patients with an extensive in situ intra-ductal component may pose a significant hurdle because the extent of ductal carcinoma in situ maybe underestimated on breast MR images. Ultimately, the success of MR-guided thermal ablation depends on the ability of MR imaging to map the extent of heating during the procedure so that the procedure can be performed to achieve complete control of the tumor margins. It is unfortunate that the conventional method for MR thermometry--the proton resonance frequency shift method--does not work in fat or in voxels with a mix of fat and glandular tissue and, hence, has limited applicability in the breast. Other methods, including measurement of T1 and T2, are being investigated as alternatives.
目前已有广泛可用的技术和设备,可实现介入性磁共振引导下的术前针定位和病变标记。微创磁共振引导下的粗针活检技术已得到证实,但对于小病变仍有局限性,而可通过磁共振成像直接可视化的活检器械的开发将有助于解决这一问题。少数中心已开始对磁共振引导下的肿瘤消融进行评估。在乳腺癌局部治疗中,朝着更大程度的保乳方向发展的持续趋势下,它有望成为一种新的治疗方式。需要进一步研究来证明磁共振引导下的消融与手术一样有效地控制肿瘤边缘的能力。原位导管内成分广泛的患者可能会构成重大障碍,因为乳腺磁共振图像上可能会低估原位导管癌的范围。最终,磁共振引导下热消融的成功取决于磁共振成像在手术过程中绘制加热范围的能力,以便能够进行手术以实现对肿瘤边缘的完全控制。遗憾的是,磁共振测温的传统方法——质子共振频率偏移法——在脂肪或脂肪与腺组织混合的体素中不起作用,因此在乳腺中的适用性有限。正在研究包括测量T1和T2在内的其他方法作为替代方案。